Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite

Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?

By Lee C   Tummon I   Martin J   Nisker J   Power S   Tekpetey F  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1157-1158

Oxford University Press

Access to resources Recommend Favorite

Case report. High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

By de Jong D  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 573-575

Oxford University Press

Access to resources Recommend Favorite

Ovarian hyperstimulation syndrome after using onadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications

By Kol S.   Lewit N.   ltskovitz-Eldor J.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1143-1144

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF

By Janssens RMJ   Vermeiden JPW   Lambalk CB   Schats R   Schoemaker J  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2386-2391

Oxford University Press

Access to resources Recommend Favorite